ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
101,898.02
-1.68%
S&P 500
6,086.37
0.61%
Dow Jones
44,156.73
0.30%
US Dollar vs Yen
156.2565
-0.12%
Brent Oil
78.225
-0.14%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Plus Therapeutics Inc (PSTV)

  7. Plus Therapeutics Inc (PSTV) ニュース

PSTV

Plus Therapeutics (PSTV)

Plus Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PSTV
日付受信時刻ニュースソース見出しコード企業名
2024/12/1721 : 30GlobeNewswire Inc.Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer SymposiumNASDAQ:PSTVPlus Therapeutics Inc
2024/12/0421 : 30GlobeNewswire Inc.Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer SymposiumNASDAQ:PSTVPlus Therapeutics Inc
2024/12/0321 : 30GlobeNewswire Inc.Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope SupplyNASDAQ:PSTVPlus Therapeutics Inc
2024/11/2521 : 30GlobeNewswire Inc.Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual ConferenceNASDAQ:PSTVPlus Therapeutics Inc
2024/11/2221 : 30GlobeNewswire Inc.Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal MetastasesNASDAQ:PSTVPlus Therapeutics Inc
2024/11/2121 : 30GlobeNewswire Inc.Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal MetastasesNASDAQ:PSTVPlus Therapeutics Inc
2024/11/1506 : 15GlobeNewswire Inc.Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:PSTVPlus Therapeutics Inc
2024/11/1506 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
2024/11/1506 : 11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
2024/11/0621 : 30GlobeNewswire Inc.Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing PartnershipNASDAQ:PSTVPlus Therapeutics Inc
2024/11/0521 : 30GlobeNewswire Inc.Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024NASDAQ:PSTVPlus Therapeutics Inc
2024/11/0121 : 30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
2024/11/0121 : 25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
2024/10/2920 : 30GlobeNewswire Inc.Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, TexasNASDAQ:PSTVPlus Therapeutics Inc
2024/10/0505 : 11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSTVPlus Therapeutics Inc
2024/10/0120 : 30GlobeNewswire Inc.Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual MeetingNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1820 : 30GlobeNewswire Inc.Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual MeetingNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1720 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1620 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1319 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1319 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1305 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1305 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1305 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1305 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1305 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1305 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1305 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1119 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
2024/09/1119 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTV

最近閲覧した銘柄

SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
NYSE
CVX
Chevron
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
AMEX
SPY
SPDR S&P 500
AMEX
XLV
Health Care Select Sector
USOTC
BASFY
BASF (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
FX
USDEUR
US Dollar vs Euro
AMEX
XLE
Energy Select Sector SPDR
CCOM
US100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有